Volume 5, 2001 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
|
Jan/Feb 2001
Pg. 6-8
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Flavoring: Compounding a Treat
Kloesel Lawson G
|
Jan/Feb 2001
Pg. 13-16
|
Autism in Children
Cave Stephanie
|
Jan/Feb 2001
Pg. 18-19
|
Methylphenidate in the Treatment of Attention Deficit Disorders
Tenreiro Kim
|
Jan/Feb 2001
Pg. 21-22
|
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature
Foy Elizabeth, MacCara Mary E
|
Jan/Feb 2001
Pg. 23-25
|
Book Reviews: Stability and Formulation References
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 25
|
Glycopyrrolate 1% Cream
Glasnapp Andrew, Shroeder B Jeanne
|
Jan/Feb 2001
Pg. 28
|
Topical Therapy for Localized Hyperhidrosis
Glasnapp Andrew
|
Jan/Feb 2001
Pg. 28-29
|
Methenamine 5% Lotion
Glasnapp Andrew, Shroeder B Jeanne
|
Jan/Feb 2001
Pg. 29
|
Compounding in History: Pediatric Considerations
Worthen Dennis B
|
Jan/Feb 2001
Pg. 30-31
|
Profile of a Practice
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 32-35
|
The Basics of Compounding Powders and Granules
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 36-39
|
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 38
|
Menthol Dusting Powder-Example of Powder Formulations
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 38
|
Cholestyramine 6.5% Ointment
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 42
|
Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 43
|
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 44
|
Lorazepam 1-mg Chewable Gummy Gels
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 45
|
Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 46
|
Milk of Magnesia Concentrate, Unflavored
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 47
|
Natural Head Lice Repellant Spray
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 48
|
Niacinamide 4% Acne Gel
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 49
|
Poison Ivy Gel with 1% Hydrocortisone
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 50
|
Promethazine HCl 50-mg/mL in PLO Gel
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 51
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina, Garcia Lea
|
Jan/Feb 2001
Pg. 52-54
|
Rhodococcus Equi Pneumonia in Foals
Davidson Gigi S
|
Jan/Feb 2001
Pg. 55-57
|
Sterile-Product Preparations: Mix or Buy?
Kastango Eric S
|
Jan/Feb 2001
Pg. 59-63
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
Purchasing Chemicals for Pharmaceutical Compounding
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 67-68
|
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Williams Kimberly Y, Baker Ma
|
Jan/Feb 2001
Pg. 69-73
|
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
Jan/Feb 2001
Pg. 73-75
|
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
Jan/Feb 2001
Pg. 75-77
|
Calculations
Prince Shelly J
|
Jan/Feb 2001
Pg. 78
|
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
|
Mar/Apr 2001
Pg. 86-88
|
Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
|
Mar/Apr 2001
Pg. 89-90
View Sample |
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
|
Mar/Apr 2001
Pg. 92-94
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
|
Mar/Apr 2001
Pg. 95-96
|
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Chan Debora Schotik
|
Mar/Apr 2001
Pg. 97-100
|
Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
|
Mar/Apr 2001
Pg. 101-103
|
A Simplified Guide to Veterinary Compounding
Bone Claire
|
Mar/Apr 2001
Pg. 104
|
Equipment for Large-Volume Aseptic Veterinary Compounding
Ahl Harvey
|
Mar/Apr 2001
Pg. 106
|
Compounded Injectables for Veterinary Use
Yoakum Jenny
|
Mar/Apr 2001
Pg. 107
|
Book Reviews: Veterinary Compounding
Reed-Kane Dana
|
Mar/Apr 2001
Pg. 108-109
|
From Wagon-Era Paregoric to Computer-Era Herbals
Newton David W
|
Mar/Apr 2001
Pg. 112-115
|
Wish You Were Here: The Niagara Apothecary
Worthen Dennis B
|
Mar/Apr 2001
Pg. 116-117
|
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 118-119
|
The Basics of Compounding Emulsions, Part 1
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 120-123
|
Diazoxide 50-mg/mL Suspension, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 126
|
Dimethyl Sulfoxide 50% Cream, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 127
|
EDTA-TRIS Otic Solution V-2 (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 128
|
Flea Bite Gel
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 129
|
Gentamicin, Polymyxin, Neomycin, and Hydrocortisone Otic Drops
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 130
|
Iodine 2% in Oil Injection
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 131
|
Methimazole 5-mg/0.1-mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 132
|
Sucrose Octaacetate and Capsicum Spray for Pets
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 133
|
Veterinary Antiseptic Emollient
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 134
|
Veterinary Oral Pastes
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 135
|
Infertility Care and the Role of the Compounding Pharmacist
Filicpzuk Janina
|
Mar/Apr 2001
Pg. 136-139
|
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing
Douglass Kate, Kastango Eric S
|
Mar/Apr 2001
Pg. 140-144
|
Ointment Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 145-146
|
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding
|
Mar/Apr 2001
Pg. 147
|
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes
Gupta Vishnu D
|
Mar/Apr 2001
Pg. 148-150
|
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
Mar/Apr 2001
Pg. 151-152
|
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Fan Bin, Stewart James T, White Catherine A
|
Mar/Apr 2001
Pg. 153-156
|
Calculations
Prince Shelly J
|
Mar/Apr 2001
Pg. 157
|
PostScription: Case Reports and Formulations, George Roentsch, RPh.
Roentsch George
|
Mar/Apr 2001
Pg. 160
|
Piracetam 100-mg, Ergoloid Mesylates 6-mg, and Selegiline 2.5-mg/0.2-mL Gel ("Brain Gel")
Roentsch George
|
Mar/Apr 2001
Pg. 160
|
Oxytetracycline 15-mg/0.1-mL TD Cream
Roentsch George
|
Mar/Apr 2001
Pg. 160
|
Motivation and Management: How to Build Your Business into the Job You Love
Beard Janet
|
May/Jun 2001
Pg. 166-169
|
A New Trend in Pharmacy Practice: Private Consultations
Kuntz Rachael L, Remmert Renee M
|
May/Jun 2001
Pg. 170-172
|
Formulations for Success in Compounding, Part 1
Vail Jane
|
May/Jun 2001
Pg. 174-175
|
Developing a Business Plan for a Compounding Specialty Pharmacy
Letendre William R, Jackson Richard A
|
May/Jun 2001
Pg. 176-179
|
Pricing Strategies
Roberts Jerrod L
|
May/Jun 2001
Pg. 180-181
|
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees
Ashworth Lisa D
|
May/Jun 2001
Pg. 182-184
|
Book Reviews: Business Topics for Compounding Pharmacists
Reed-Kane Dana
|
May/Jun 2001
Pg. 185
|
Software for the Compounding Pharmacist: A Review
Capps Shelly
|
May/Jun 2001
Pg. 187-189
|
Capsule-Weighing and Trituration Calculations
Newton David W
|
May/Jun 2001
Pg. 192-194
|
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study
Curtis Larry, Biundo Bruce
|
May/Jun 2001
Pg. 195
|
Compounding in History: Compounding Economics
Worthen Dennis B
|
May/Jun 2001
Pg. 196-197
|
The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
|
May/Jun 2001
Pg. 198-201
|
Dry Skin and Massage Lotion-Example
Allen Loyd V Jr
|
May/Jun 2001
Pg. 201
|
Amphotericin 5-mg/mL Nasal Inhalation
Allen Loyd V Jr
|
May/Jun 2001
Pg. 204
|
Anthralin 1% in Lipid Crystals Cream
Allen Loyd V Jr
|
May/Jun 2001
Pg. 205
|
Bifonazol 1% and Urea 40% in White Petrolatum
Allen Loyd V Jr
|
May/Jun 2001
Pg. 206
|
Hand Cream, Protective
Allen Loyd V Jr
|
May/Jun 2001
Pg. 207
|
Idoxuridine 15% in Dimethyl Sulfoxide (DMSO)
Allen Loyd V Jr
|
May/Jun 2001
Pg. 208
|
Mitomycin 0.02% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2001
Pg. 209
|
Phenytoin 100- to 400-mg Rectal Suppositories
Allen Loyd V Jr
|
May/Jun 2001
Pg. 210
|
Tacrolimus 0.3% Ointment
Allen Loyd V Jr
|
May/Jun 2001
Pg. 211
|
Tetracycline HCl 1% Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2001
Pg. 212
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2001
Pg. 213
|
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
|
May/Jun 2001
Pg. 214-215
|
The American Veterinary Medical Association Compounding Position Statement
Davidson Gigi S
|
May/Jun 2001
Pg. 216-217
|
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Girouard Lorinda G, Holm Richard C
|
May/Jun 2001
Pg. 218-220
|
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective
Kastango Eric S, DeMarco Sam
|
May/Jun 2001
Pg. 221-225
View Sample |
Establishing and Maintaining a Compounding Pharmacy Reference Library
Allen Loyd V Jr
|
May/Jun 2001
Pg. 226-227
|
Official Water-Repelling Agents: The Official Silicones, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2001
Pg. 228
|
Calculations
Prince Shelly J
|
May/Jun 2001
Pg. 229
|
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
May/Jun 2001
Pg. 230-231
|
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid
Gupta Vishnu D, Ling Jie
|
May/Jun 2001
Pg. 232-233
|
Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories
Anderson Derick, Amiji Mansoor M
|
May/Jun 2001
Pg. 234-237
|
PostScription: Compounding Pharmacists
Jackson Richard A
|
May/Jun 2001
Pg. 240
|
Stoughton's Bitters
Worthen Dennis B
|
May/Jun 2001
Pg. 197
|
Tinctura Kino Composita
Allen Loyd V Jr
|
May/Jun 2001
Pg. 197
|
Quality Assurance for Sterile Products
Kastango Eric S, Douglass Kate
|
Jul/Aug 2001
Pg. 246-253
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
Bacterial Endotoxins and Pyrogens
Jones Marty
|
Jul/Aug 2001
Pg. 259-263
|
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 265-267
|
Antineoplastic Agents
Ashworth Lisa D
|
Jul/Aug 2001
Pg. 268-271
|
Compounding Issues and Accreditation Agencies
Petroff Barb
|
Jul/Aug 2001
Pg. 273-274
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2001
Pg. 275-276
|
Sterile Compounding: Excerpts from the Reviews of Current Published Literature
MacCara Mary E
|
Jul/Aug 2001
Pg. 278-279
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
|
Jul/Aug 2001
Pg. 282-283
|
Analytical Testing Facilities and Products
Hudson Sonora
|
Jul/Aug 2001
Pg. 284-286
|
Formulations for Success, Part 2
Vail Jane
|
Jul/Aug 2001
Pg. 287-289
|
Wish You Were Here: The Stabler-Leadbeater Apothecary Museum
Worthen Dennis B
|
Jul/Aug 2001
Pg. 290-292
|
Basics of Compounding: Suspensions
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 294-297
|
Suspension Structured Vehicle, USP
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 296
|
Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 296
|
Spironolactone Oral Suspension 2-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Progesterone Oral Suspension 40-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Progesterone Enema 200-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Xanthan Gum Oral Suspension Vehicle 0.3%
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Wound Care Mixture
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 300
|
Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 301
|
Fibrin Glue
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 302
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 303
|
Hypertonic Sodium Chloride 20% Sclerotherapy Injections
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 304
|
Metronidazole and Neomycin Sulfate Irrigation Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 305
|
Pediatric Preoperative Cocktail Injection
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 306
|
Phenylephrine 0.25% Ophthalmic Solution, Preservative Free
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 307
|
Sclerotherapy Injections of Phenol for Pain Management
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 308
|
Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 309
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Maintenance of the Cleanroom
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 313
|
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
|
Jul/Aug 2001
Pg. 314-319
|
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
|
Jul/Aug 2001
Pg. 320-322
|
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Quay Irene, Tan Edward
|
Jul/Aug 2001
Pg. 323-324
|
Calculations
Prince Shelly J
|
Jul/Aug 2001
Pg. 325
|
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Gupta Vishnu D
|
Jul/Aug 2001
Pg. 328
|
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Reed-Kane Dana
|
Sep/Oct 2001
Pg. 332-335
View Sample |
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
|
Sep/Oct 2001
Pg. 336-338
|
Bioidentical Hormones in the Treatment of Osteoporosis
Boomsma Diane
|
Sep/Oct 2001
Pg. 339-341
|
The Value of Hormone Assessment
Collins Joseph J
|
Sep/Oct 2001
Pg. 342-344
|
Estrogen Replacement: A Review of Current Literature
Parazewski Kevin
|
Sep/Oct 2001
Pg. 346-350
|
Treating Andropause: Prohormones and Hormone Metabolic Modifiers
Biundo Bruce
|
Sep/Oct 2001
Pg. 351-353
|
Bioidentical Topical Progesterone: A Survey of Patients
Warren Aileen, Listecki Robert E
|
Sep/Oct 2001
Pg. 354-355
|
Book Reviews: Hormone Replacement Therapy
Paoletti James E
|
Sep/Oct 2001
Pg. 356-357
|
Charting Systems: Organizing Information Effectively
Anneken Michael W, Flick Celeste C
|
Sep/Oct 2001
Pg. 360-361
|
Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
|
Sep/Oct 2001
Pg. 362-364
|
Compounding in History: Treatment at the Change of Life
Worthen Dennis B
|
Sep/Oct 2001
Pg. 365-367
|
The Basics of Compounding: Tablets and Pills
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 369-371
|
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 374
|
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 375
|
Libido Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 376
|
Progesterone 50-mg/mL Clear Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 377
|
Progesterone Low-Potency 0.0065% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 378
|
Sildenafil 1% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 379
|
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 380
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 381
|
Testosterone 25-mg/mL Clear Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 382
|
Testosterone 2% Scalp Lotion
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 383
|
Compounding Containment Devices: Buyer Be Aware
Kastango Eric S
|
Sep/Oct 2001
Pg. 384-388
|
Capsule and Tablet Disintegrating Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 389-390
|
Calculations
Prince Shelly J
|
Sep/Oct 2001
Pg. 391
|
Developing a Capsule Formulation
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 392-393
|
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L, Stewart James T, Warren Flynn W
|
Sep/Oct 2001
Pg. 394-396
|
Assessment of the Stability of Teicoplanin in Intravenous Infusions
Galanti Laurence M, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques
|
Sep/Oct 2001
Pg. 397-400
|
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H, Szwejkowski Jessica, Houston Alana
|
Sep/Oct 2001
Pg. 401-405
|
PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 408
|
Flush Powder, No. 2
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Tincture of Black Cohosh
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Lydia Pinkham's Vegetable Compound
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 412-419
|
High-tech Rx Compliance
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 419
|
High-tech Marketing Techniques
Gonzalez Mark A
|
Nov/Dec 2001
Pg. 420-421
|
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Karolchyk Scott
|
Nov/Dec 2001
Pg. 422-423
|
Nanotechnology: The Ultimate Alchemy
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 424-425
|
Future Trends in High-technology Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 426
|
Using Technology to Enhance the Practice of Pharmacy
Fox Brent L, Felkey Bill G
|
Nov/Dec 2001
Pg. 427-429
|
Tips for Preventing Viruses…
Capps Lale
|
Nov/Dec 2001
Pg. 430-433
|
Topical Secretin for the Treatment of Autism
King Erin, Toney Steve
|
Nov/Dec 2001
Pg. 436-437
|
Wish You Were Here: Vienna, Austria
Worthen Dennis B
|
Nov/Dec 2001
Pg. 438-439
|
Basics of Compounding: Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 441-447
|
Acetic Acid 5% Iontophoresis Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 450
|
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 451
|
Dexamethasone, Lidocaine, and Verapamil Iontophoresis Solutions for Peyronie's Disease
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 452
|
Doxycycline Hyclate 200-mg/mL Avian Injection
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 453
|
Hydrocortisone 10% Phonophoresis Gel
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 454
|
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 455
|
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 456
|
Tobramycin-impregnated Polymethylmethacrylate Beads
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 457
|
Total Parenteral Nutrition Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 458
|
Vancomycin 5-mg Sponge Disks
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 459
|
Hormone Replacement Therapy, Part 2: Estrogen Defined
Lorentzen Jean
|
Nov/Dec 2001
Pg. 460-461
|
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S, Hadaway Lynn
|
Nov/Dec 2001
Pg. 465-469
|
Tablet and Lozenge Binders, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 471-473
|
Training Personnel
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 474-475
|
Cross-contamination in Porcelain Mortars
Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
|
Nov/Dec 2001
Pg. 476-479
|
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Gupta Vishnu D
|
Nov/Dec 2001
Pg. 480-481
|
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes
Gupta Vishnu D
|
Nov/Dec 2001
Pg. 482-484
|
Calculations
Prince Shelly J
|
Nov/Dec 2001
Pg. 485
|
PostScription: Lifelong Learning + Technology = Valuable Tools for the Compounding Pharmacist
Letendre William R
|
Nov/Dec 2001
Pg. 488
|
Return to Top |